Suzhou Ribo Life Science
Kunshan
About Suzhou Ribo Life Science
Suzhou Ribo Life Science is a developer of RNA interference ( RNAi ) technology designed to treat liver diseases. The company's RNA interference ( RNAi ) technology is used to develop nucleic acid therapeutic drugs and related products, enabling healthcare providers to deliver more effective pharmaceuticals to patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $169.4M
- Funding stage: IPO
- Last round: Series E (Jul 2025)
- Ticker: hkg:6938
- Website: ribolia.com
- Phone: 86 512 5701 7802
Industries & Categories
Biotechnology, Genetics, Medical
Social Profiles
Canonical: https://fsome.com/organization/suzhou-ribo-life-science-122617 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.